Nicole Lustig

Nicole Lustig

Auto-generated profile, based on publicly available information

Nicole Lustig

Department of Endocrinology, Faculty of Medicine Pontificia Universidad Católica de Chile Santiago Chile

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MSMarlín Solórzano
Marlín Solórzano
NLNicole Lustig
Nicole Lustig
LMLorena Mosso
Lorena Mosso
MEMartín Espinoza
Martín Espinoza
RSRoberto Santana
Roberto Santana
JDJosé Miguel Domínguez
José Miguel Domínguez
Objective: After initial treatment, up to 30% of patients with papillary thyroid cancer (PTC) have incomplete response, mainly cervical lymph node (LN) disease. Previous studies have suggested that active surveillance (AS) is a possible option for these patients. Our aim was to report the results of AS in patients with PTC and cervical LN disease. Materials and methods: In this retrospective observational study, we included adult patients treated and followed for PTC, who presented with cervical LN disease and [...] ABSTRACT Objective: After initial treatment, up to 30% of patients with papillary thyroid cancer (PTC) have incomplete response, mainly cervical lymph node (LN) disease. Previous studies have suggested that active surveillance (AS) is a possible option for these patients. Our aim was to report the results of AS in patients with PTC and cervical LN disease. Materials and methods: In this retrospective observational study, we included adult patients treated and followed for PTC, who presented with cervical LN disease and

19 June 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RORoberto Olmos
Roberto Olmos
FMFrancisco Muñoz
Francisco Muñoz
FDFrancisca Donoso
Francisca Donoso
JLJorge López
Jorge López
MBMaría José Bruera
María José Bruera
JDJosé Miguel Domínguez
José Miguel Domínguez
Objective: Warthin-like papillary thyroid cancer (WL-PTC) is an uncommon variant of PTC, usually associated with lymphocytic thyroiditis. Scarce evidence suggests that WL-PTC has similar clinical presentation to classic PTC (C-PTC), with no studies comparing risks of recurrence and response to treatment between both variants. Our objective was to describe the clinical presentation and prognosis of WL-PTC and compare it to C-PTC. Subjects and methods: Retrospective analysis of a prospective cohort, including 370 (96%) patients with C-PTC and 17 (4%) with WL-PTC, consecutively treated with total thyroidectomy with or without RAI, followed for at least 6 months. We compared clinical presentation, risk of mortality and recurrence, as well as response to treatment between both variants. Results: Of the total cohort: 317 (82%) female, 38 +/- 13.5 years, median follow-up 4 years (0.5-28.5); most of them stage I and low/intermediate risk of recurrence. We found no differences regarding clinical-pathological data and risk of recurrence. WL-PTC was associated with a higher rate of anti-thyroglobulin antibodies (TgAb) (65% vs. 36%, p = 0.016) and lymphocytic thyroiditis (59% vs. 34%, p = 0.03). The rates of biochemical and structural incomplete responses were similar in both variants. WL-PTC had a lower rate of excellent response (23% vs. 54%, p = 0.01), which became non-significant when performing analysis by TgAb presence (50% vs. 67%, p = NS). Conclusions: WL-CPT and C-CPT have similar clinical presentation and rate of recurrence. The lower rate of excellent response to treatment in WL-PTC is due to a higher frequency of TgAb.WL-PCT should not be considered an aggressive variant of PTC.

1 August 2013 in Revista chilena de infectología
Verified
Journal Article
Open access
PDF file
AMArnaldo Marín
Arnaldo Marín
NLNicole Lustig
Nicole Lustig
RCRicardo Cruz
Ricardo Cruz
SCSamuel Cordova
Samuel Cordova
Infective endocarditis caused by Listeria monocytogenesis an extremely rare but usually aggressive disease. We have seen in recent years an increase in age of onset of this disease and a predilection for patients with valvular disease, especially prosthetic valve. The treatment of choice is ampicillin, which is combined with gentamicin for synergy. It is known that even with treatment the mortality is very high and higher than in other types of bacterial endocarditis. With optimal therapy, that is medical-surgical, mortality has declined significantly in recent years. We presents a review of the literature and a clinical case of a patient with a febrile syndrome diagnosed as a infective endocarditis caused by L. monocytogenestreated medically with successful outcome to date.

22 May 2026 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
NLNicole Lustig
Nicole Lustig
JDJosé Miguel Domínguez
José Miguel Domínguez
SVSergio Vargas‐Salas
Sergio Vargas‐Salas
MHMaría Paz Hernandez
María Paz Hernandez
LMLorena Mosso
Lorena Mosso
HGHernán E. González
Hernán E. González

19 July 2026 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
IFIgnacio Fuentes
Ignacio Fuentes
MSMarlín Solórzano
Marlín Solórzano
AMAnnette Madison
Annette Madison
JFJoel Falcón
Joel Falcón
CRCatalina Ruiz
Catalina Ruiz
JDJosé M. Domínguez
José M. Domínguez

4 June 2026 in Medwave
Verified
Journal Article
Closed access
NLNicole Lustig
Nicole Lustig
LRLeticia Rincón
Leticia Rincón
JQJuan Carlos Quintana
Juan Carlos Quintana
VIVirginia Iturrieta
Virginia Iturrieta
IFIgnacio Fuentes
Ignacio Fuentes
JDJosé Miguel Domínguez
José Miguel Domínguez